![Elizabeth Ng](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Elizabeth Ng
Directeur/Membre du Conseil chez
OCEAN BIOMEDICAL, INC.
Fortune : 114 442 $ au 30/06/2026
Profil
Elizabeth Ng is Chief Executive Officer at Ocean Biomedical Holdings, Inc. since 2019.
Ms. Ng is Independent Director at AIRO Group Holdings, Inc. starting 2025.
Ms. Ng is Director at CRISP-HR Therapeutics Inc. Ms. Ng is Executive Director at Ocean Biomedical, Inc. starting 2025.
Formerly, Ms. Ng was Chief Executive Officer & Director at Ocean Biomedical, Inc. from 2023 to 2024.
Ms. Ng was Director-Commercial & Portfolio Strategy at Gilead Sciences, Inc. Ms. Ng was Director-Strategy Development Group at Merck & Co., Inc. Ms. Ng was Senior Director-Portfolio Strategy at BioMarin Pharmaceutical, Inc. from 2010 to 2017.
Ms. Ng was Senior Director Engagement Manager at Strategic Decisions Group.
Ms. Ng was Vice President-Strategy & Business Development at Bioelectric Devices, Inc. Ms. Ng earned an MBA from Stanford University.
Ms. Ng completed undergraduate studies at Massachusetts Institute of Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/06/2026 | 15 486 ( 0,06% ) | 114 442 $ | 30/06/2026 |
Postes actifs de Elizabeth Ng
| Sociétés | Poste | Début |
|---|---|---|
| OCEAN BIOMEDICAL, INC. | Directeur/Membre du Conseil | 28/03/2025 |
| AIRO GROUP HOLDINGS, INC. | Directeur/Membre du Conseil | 01/06/2025 |
Ocean Biomedical, Inc. (United States)
 Ocean Biomedical, Inc. (United States) Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Général | 02/01/2019 |
CRISP-HR Therapeutics Inc.
 CRISP-HR Therapeutics Inc. Internet Software/ServicesTechnology Services Develops CRISPR platform to create novel therapeutics for rare diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Elizabeth Ng
| Sociétés | Poste | Fin |
|---|---|---|
| OCEAN BIOMEDICAL, INC. | Directeur Général | 23/10/2024 |
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01/01/2017 |
Strategic Decisions Group
 Strategic Decisions Group Miscellaneous Commercial ServicesCommercial Services Provides consulting solutions | Corporate Officer/Principal | - |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Formation de Elizabeth Ng
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Strategic Decisions Group
Strategic Decisions Group Miscellaneous Commercial ServicesCommercial Services Provides consulting solutions | Commercial Services |
Ocean Biomedical, Inc. (United States)
Ocean Biomedical, Inc. (United States) Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Bioelectric Devices, Inc.
 Bioelectric Devices, Inc. Miscellaneous Commercial ServicesCommercial Services Develops AI driven bioelectronics | Commercial Services |
CRISP-HR Therapeutics Inc.
CRISP-HR Therapeutics Inc. Internet Software/ServicesTechnology Services Develops CRISPR platform to create novel therapeutics for rare diseases | Technology Services |
AIRO Group Holdings, Inc.
 AIRO Group Holdings, Inc. Aerospace & DefenseElectronic Technology Manufactures and sells drones, military and civil aircraft, flights & offers pilot training services | Electronic Technology |
Ocean Biomedical, Inc.
 Ocean Biomedical, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
